Clinical trial data anonymization

100+ clinical trial data sets delivered on time, over 20% cost savings realized

The challenge

A large, global pharmaceutical sponsor needed to scale its data sharing as part of its effort to drive greater advancements in patient health. 

This objective required anonymizing a backlog of clinical trial structured patient data not yet published for researchers. 

Many of these studies were large and complex. Some of the studies covered a pool of trials over 30,000 participants and 5,000 variables, and others with multiple extension studies.

The solution

The drug sponsor leveraged Privacy Analytics’ service to anonymize the studies using a proven statistical, risk-based methodology.

The results

  • Over 100 datasets were delivered in two quarters (7 months), each with statistical proof of compliance under the General Data Protection Regulation (GDPR) and other applicable regulations.
  • Data utility was maximized to accelerated high-priority analytics projects with health research partners. Privacy Analytics implemented tailored data utility optimizations to address specific researcher needs.
  • In addition to the initial efficiency gains, the sponsor also realized more than 20% in cost savings over time.

Privacy Analytics can help your company quickly anonymize structured patient data.

More Case Studies


Join the next 5 Safes Data Privacy webinar

This course runs on the 2nd Wednesday of every month, at 11 a.m. ET (45 mins). Click the button to register and select the date that works best for you.